Executive Management Committee

Chair: Professor Stephen Leeder AO
Director of the Research and Education Network, Western Sydney Local Health District

Professor Leeder is the Director of the Research and Education Network, Western Sydney Local Health District. He is also emeritus Professor of Public Health and Community Medicine at the University of Sydney and the editor-in-chief of the International Journal of Epidemiology.

Professor Leeder’s academic career includes public health research, educational development and policy, with research interests in asthma and cardiovascular disease. From 2011 to December 2016, Professor Leeder was the chair of the Western Sydney Local Health District Board, from 1997 to 2003 dean of the Faculty of Medicine at the University of Sydney and, from 2004 to 2014 he directed the Menzies Centre for Health Policy, focussing on policy research for cost-effective, comprehensive prevention and care of chronic illnesses.

Dr Teresa Anderson AM
Chief Executive, Sydney Local Health District

Dr Anderson has more than 30 years’ experience as a clinician and health service executive. Her roles included General Manager, Liverpool Hospital and Director, Clinical Operations, Former Sydney South West Area Health Service.

She has a well-established reputation for implementing strategies to foster innovation and best practice, supporting collaboration and building partnerships, to provide excellent health care to almost 700,000 people living within SLHD and beyond.

Dr Anderson is a speech pathologist, internationally recognised for her specialist knowledge and skills in research, assessment and management of paediatric and adult dysphagia, early communication development, early childhood development and early intervention.

In addition to serving on both the Governing Council and the Executive Management Committee of Sydney Health Partners, Dr Anderson is a member of nine medical research and PHN boards.

Professor Warwick Britton AO
Research Director, Sydney Local Health District

Warwick Britton is Bosch Professor of Medicine and Professor of Immunology at the University of Sydney, head of the Tuberculosis Research Program at the Centenary Institute, and Research Director for Sydney Local Health District.

He has longstanding interests in the immunology of mycobacterial infections and the control of tuberculosis and leprosy, including the development of novel vaccines and drugs against TB. Currently he is CIA on the NHMRC-funded Centre for Research Excellence in Tuberculosis Control: from Discovery to Public Health Policy and Practice. This Centre includes research collaborations on the role of active case finding and community screening for tuberculosis in Vietnam, host susceptibility to tuberculosis infection, mycobacterial epidemiology and drug resistance, and the development of more effective tools to aid tuberculosis control.

Dr Michael Brydon
Chief Executive, Sydney Children’s Hospitals Network

Dr Michael Brydon was permanently appointed to the role of Chief Executive of the Sydney Children’s Hospitals Network in July 2016, having previously served as the Acting Chief Executive and Director of Clinical Operations.

Prior to the Network forming, Dr Brydon worked at the Sydney Children’s Hospital, Randwick for 27 years. In the last two decades, he has established a wide network of personal partnerships, predominantly in the child health environment and gained significant expertise in clinical management and medical administration. Ever since entering paediatrics, Michael has advocated for children and their families, highlighting the differences in their needs and ensuring a fair allocation of resources to paediatrics.

Professor Arthur Conigrave
Dean of Sydney Medical School, University of Sydney

Professor Arthur Conigrave was appointed Dean of Sydney Medical School in 2017. Prior to this appointment, Professor Conigrave held a number of leadership roles including Acting Dean in 2016, Deputy Dean and Associate Dean (Finance & Administration) from 2011, and Head of the School of Molecular Bioscience from 2007-10. Professor Conigrave is an Endocrinologist specialising in the clinical management of patients with metabolic bone disease (including osteoporosis and disorders of calcium metabolism), and an internationally recognised researcher in molecular endocrinology.

He also serves as a Director of the Centenary Institute and the Woolcock Institute of Medical Research.

Professor Garry Jennings AO
Executive Director, Sydney Health Partners

Professor Garry Jennings AO is the Executive Director of Sydney Health Partners and has extensive experience in health and medical research, specialising in cardiology. He served as the Director of Baker IDI Heart and Diabetes Institute in Melbourne for 14 years and most recently as the Interim CEO of the National Heart Foundation. He has had a long association with the National Heart Foundation as a former Board Member and Chair of its Cardiovascular Health Advisory Committee.

As a leading cardiologist, Professor Jennings has also had a long career in clinical practice including as the Director of Cardiology at The Alfred Hospital, Melbourne. Professor Jennings also played a key role in the transformation of The Alfred campus as Foundation Chair of the Alfred Medical Research and Education precinct. As a researcher, his interests include the prevention and treatment of cardiovascular disease.

Professor Jennings was appointed an Officer of the Order of Australia in 2013 for his service to medical research and the prevention and control of cardiovascular disease, obesity and diabetes.

Danny O’Connor
Chief Executive, Western Sydney Local Health District

Danny was appointed chief executive of the Western Sydney Local Health District (WSLHD) in January 2011.
He believes the primary purpose of healthcare is to improve people’s lives.

Central to success is a strong partnership with consumers in continually improving services. Likewise, a robust collaboration is required between science and practice to ensure the continuous evolution of best practice in clinical care and population health programs.

Danny currently serves on the boards of the WSLHD (ex-officio), Westmead Institute for Medical Research, NSW HealthShare, and the Westmead Medical Research Foundation.

Professor Vlado Perkovic,
Executive Director, The George Institute Australia

Vlado Perkovic is Executive Director of the George Institute, Australia, Professor of Medicine at the University of Sydney, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several major international clinical trials, serves on the Steering Committees of several others, and has led the development of George Clinical, the global clinical trials arm of The George Institute. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management.

Vlado holds a Doctor of Philosophy from the University of Melbourne and completed his undergraduate training at the Royal Melbourne Hospital. He is a member of the National Health and Medical Research Council Principal Committee on Research Translation; is Chair of the International Society of Nephrology Action for Clinical Trials (ISN-ACT) group; and is a Fellow of the Royal Australasian College of Physicians, of the Australian Academy of Health and Medical Sciences and of the American Society of Nephrology.

He is also a Lead of Sydney Health Partners’ Renal Thematic Research stream. 

Professor Laurent Rivory
Pro-Vice Chancellor (Strategic Collaborations and Partnerships), University of Sydney

Professor Rivory has 20 years’ experience in research and leadership, which has spanned the higher education, hospital and industry sectors. He is widely recognised for his research in cancer drug pharmacology through appointments at the University of Queensland, the Royal Prince Alfred Hospital, the Université de Bordeaux II and the Fondation Bergonié, and the University of Sydney. Professor Rivory also served as Senior Research Director, Research and Development, at Johnson and Johnson Research and was most recently Director of the Research Strategy Office at the University of New South Wales.

As PVC (SC&P), Professor Rivory’s responsibilities include the large-scale collaborations such as the Charles Perkins Centre and the Brain and Mind Centre, the Core Research Facilities and the management of external partnerships, particularly in health.  He has a strong interest in ensuring that these enable increased scale and translation of health research at the University of Sydney.

Deborah Willcox
Chief Executive, Northern Sydney Local Health District

Deb commenced at the Chief Executive, Northern Sydney Local Health District (NSLHD) in November 2017. Her career has included roles in both government and non-government organisations and her experience spans clinical, corporate services, government departments, the research environment and senior government advisor roles.

Prior to her appointment as the Chief Executive, NSLHD, Deb held a number of senior executive and leadership positions within NSW Health including the Director of Operations Sydney Local Health District and General Manager, Royal Prince Alfred Hospital, the Director, Customer Service and Corporate Governance HealthShare NSW, and Director Executive of and Ministerial Services, NSW Health.

Deb has also held senior positions in government both as Chief of Staff in the portfolios of Planning, Housing and Aboriginal Affairs where she played a pivotal role in the development and implementation of the Government’s policy agenda in the portfolios of Planning, Housing and Aboriginal Affairs, and as an advisor to the Deputy Premier and Minister for Health, overseeing clinical areas including planned surgery, critical care, and emergency departments for these portfolios.

Deb started her career in nursing at Royal Prince Alfred Hospital and later studied law having been admitted as a Legal Practitioner in New South Wales.


© 2018 Sydney Local Health District
Disclaimer | Privacy Statement | Accessibility
Page Last Updated: 03 September, 2018